Showing results (161-170 of 279) with videos related to
Sort By:
Pageof 28
Leukemia & Lymphoma|May 31, 2022
Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective studyTamar Berger, Karyn Revital Geiger, Moshe Yeshurun, et al.Cancer Genetics|October 17, 2015
Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxideDaniel Shepshelovich, Nino Oniashvili, Doris Parnes, et al.Leukemia|June 10, 2026
Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analysisRamon Cohen, Shay Nemet, Shira Bezalel-Rosenberg, et al.Journal of Thrombosis and Haemostasis : JTH|October 12, 2023
Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and MalignancyGerald Soff, Avi Leader, Hanny Al-Samkari, et al.Pathology, Research and Practice|December 10, 2019
Genomic analysis of metastatic rhabdomyosarcoma masquerading as acute leukemiaOren Pasvolsky, Lucille Heiman, Aron Popovtzer, et al.Journal of Clinical Medicine|June 26, 2025
Bullous Pemphigoid as a Manifestation of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Report of a Novel CaseSapir Glazer Levavi, Moshe Yeshurun, Pia Raanani, et al.Cancer Letters|February 21, 2015
Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatmentOshrat Hershkovitz-Rokah, Shira Modai, Metsada Pasmanik-Chor, et al.Haematologica|April 2, 2009
Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysisRonit Gurion, Anat Gafter-Gvili, Mical Paul, et al.Leukemia Research|December 15, 2015
Uninvolved immunoglobulins predicting hematological response in newly diagnosed AL amyloidosisEli Muchtar, Hila Magen, Gilad Itchaki, et al.Cancer Letters|October 12, 2014
MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL proteinOshrat Hershkovitz-Rokah, Shira Modai, Metsada Pasmanik-Chor, et al.Pageof 28